Published in Hypertension on August 01, 1996
TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest (2002) 2.35
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J Clin Invest (2001) 2.03
Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. Proc Natl Acad Sci U S A (2000) 1.93
Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev (2003) 1.84
Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes. J Physiol (2003) 1.22
Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol (1999) 1.20
Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction. Am J Physiol Heart Circ Physiol (2007) 1.04
Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling. Clin Sci (Lond) (2014) 0.87
LV hypertrophy and diastolic heart failure. Heart Fail Rev (2000) 0.85
Hypertension research program at ochsner: a program in translational research. Ochsner J (2002) 0.76
The effect of non-antihypertensive doses of angiotensin converting enzyme inhibitor on myocardial necrosis and hypertrophy in young rats with renovascular hypertension. Int J Exp Pathol (1999) 0.75
Functional and metabolic evaluation of the hypertrophied heart using MRI and 31P-MRS. MAGMA (1998) 0.75
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
The origin of man: a chromosomal pictorial legacy. Science (1982) 4.02
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension (2001) 2.20
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation (1968) 1.82
Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res (1981) 1.75
One-year longitudinal study of a no-smoking policy in a medical institution. Chest (1990) 1.75
Glycosuria in organophosphate and carbamate poisoning. J Assoc Physicians India (2000) 1.74
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
Essential Oil Composition and Antibacterial Studies of Vitex negundo Linn. Extracts. Indian J Pharm Sci (2010) 1.71
A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 1.65
Evaluation of the initial care of hypertensive patients. JAMA (1971) 1.64
Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med (1966) 1.57
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up. Cardiovasc Res (2000) 1.49
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
A comparative evaluation of formol-ether, zinc sulphate and magnesium sulphate concentration techniques for diagnosis of helminthic ova and protozoal cysts. Indian J Med Res (1967) 1.40
The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol (1989) 1.39
Hypertension means high blood pressure. Hypertension (1994) 1.39
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Purification and properties of the biotin repressor. A bifunctional protein. J Biol Chem (1982) 1.33
Biotinyl 5'-adenylate: corepressor role in the regulation of the biotin genes of Escherichia coli K-12. Proc Natl Acad Sci U S A (1979) 1.33
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Properties of alpha-dehydrobiotin-resistant mutants of Escherichia coli K-12. J Bacteriol (1975) 1.30
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Characterization of antifungal metabolite produced by a new strain Pseudomonas aeruginosa PUPa3 that exhibits broad-spectrum antifungal activity and biofertilizing traits. J Appl Microbiol (2005) 1.26
Removal of Cr(VI) from aqueous solutions using agricultural waste 'maize bran'. J Hazard Mater (2007) 1.23
Structural alterations in the long terminal repeat of an acquired mouse mammary tumor virus provirus in a T-cell leukemia of DBA/2 mice. Virology (1987) 1.19
Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J Natl Cancer Inst Monogr (2001) 1.18
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Active transport of biotin in Escherichia coli K-12. J Bacteriol (1974) 1.16
Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol (1979) 1.14
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
Small reovirus particle composed solely of sigma NS with specificity for binding different nucleic acids. J Virol (1981) 1.12
Antigenic analysis of different strains of Brucella. Indian J Med Res (1971) 1.12
Left ventricular hypertrophy and sudden death. J Am Coll Cardiol (1998) 1.11
Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am J Physiol (1978) 1.10
Incidence of postoperative posterior capsular opacification with types of senile cataracts. J Cataract Refract Surg (1992) 1.09
A renewed call to mentor. Hypertension (2000) 1.08
Editorial: Use and abuse of diuretics. Am Heart J (1975) 1.07
Typhoid perforation treated by closure and proximal side to side ileotransverse colostomy. J Indian Med Assoc (1975) 1.07
Microbial community structure and activity linked to contrasting biogeochemical gradients in bog and fen environments of the Glacial Lake Agassiz Peatland. Appl Environ Microbiol (2012) 1.06
Proposal of biostimulation for hexachlorocyclohexane (HCH)-decontamination and characterization of culturable bacterial community from high-dose point HCH-contaminated soils. J Appl Microbiol (2009) 1.06
Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res (1976) 1.06
Topographical requirements for delta-selective opioid peptides. Biopolymers (1991) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
The in vitro activity of tinidazole and other amoebicidal drugs on locally isolated strains of Entamoeba histolytica. Indian J Med Res (1970) 1.06
The effect of an educational program to improve health-related quality of life in patients with osteoarthritis on waiting list for total knee replacement: a randomized study. Osteoarthritis Cartilage (2005) 1.04
A study of spontaneous echo contrast in patients with rheumatic mitral stenosis and normal sinus rhythm: an Indian perspective. Br Heart J (1995) 1.04
In vitro synthesis and and regulation of the biotin enzymes of Escherichia coli K-12. J Bacteriol (1978) 1.03
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold. Biochemistry (1997) 1.02
Cardiorespiratory and metabolic effects of profound hypothermia. Crit Care Med (1978) 1.01
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Proteins encoded by the long terminal repeat region of mouse mammary tumor virus: identification by hybrid-selected translation. J Virol (1984) 1.01
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (2001) 1.00
Recent advances on large arteries in hypertension. Hypertension (1998) 1.00
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Physiological comparison of labile and essential hypertension. Circ Res (1970) 0.99
Molecular cloning, characterization, and genetic mapping of an endogenous murine mammary tumor virus proviral unit I of C3H/He mice. J Virol (1985) 0.99
Beta adrenergic blockade in the circulatory regulation of hyperkinetic states. Am J Cardiol (1971) 0.98
Recommendations for blood pressure determination by sphygmomanometry. Ann Intern Med (1988) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Comparison of the clinical profile and outcome for squamous cell carcinoma and adenocarcinoma of the distal esophagus and cardia in India. Surg Today (2001) 0.97
A clinical trial of Mebendazole (R17,635) in cases of hookworm infection. Indian J Med Res (1972) 0.97
Endogenous mouse mammary tumor virus Mtv-17 is involved in Mtv-2-induced tumorigenesis in GR mice. Virology (1996) 0.97
Re-examination of the hemodynamics of hypertension. Am J Med Sci (1969) 0.96
Effects of weight reduction on arterial pressure. J Chronic Dis (1982) 0.95
Total vascular pressure-volume relationship in the conscious rat. Am J Physiol (1980) 0.95
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension (1997) 0.95
Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation (1966) 0.94
Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. Br Heart J (1969) 0.94
Left atrial abnormality and ventricular preejection period in hypertension. Dis Chest (1969) 0.94
Renal haemodynamic studies in obesity hypertension. J Hypertens (1987) 0.94
Aetiopathogenesis of scleroma. J Laryngol Otol (1969) 0.94
Immediate hemodynamic effects of urapidil in patients with essential hypertension. Am J Cardiol (1985) 0.93
Regional blood flow in normotensive and spontaneously hypertensive rats. Am J Physiol (1976) 0.93
Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension. Am J Cardiol (1985) 0.93
Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Circulation (1981) 0.93
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol (1983) 0.93
Devices used for self-measurement of blood pressure. Revised statement of the National High Blood Pressure Education Program. Arch Intern Med (1985) 0.93
Systemic and regional hemodynamics in low, normal and high cardiac output borderline hypertension. Circulation (1978) 0.93
Chemotherapy and chemoprophylaxis of experimental toxoplasmosis. Indian J Med Res (1972) 0.93
Prevalence of occupational asthma in silk filatures. Ann Allergy (1985) 0.93
Plasma volume changes with long-term beta-adrenergic blockade. Am Heart J (1971) 0.92